Randomized Double-blind Controlled Study of Shenshi Shengdiqinlian Tufuling Decoction in the Treatment of Mucocutaneous Behcet's Disease
Phase 1
- Conditions
- Behcet's Disease
- Registration Number
- ITMCTR2000003766
- Lead Sponsor
- Shanghai Traditional Chinese Medicine Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Aged >= 16 years;
2. In compliance with the 2013 International Behets disease diagnostic criteria;
3. The patient or his family members signed the informed consent.
Exclusion Criteria
Exclude other autoimmune diseases (systemic lupus erythematosus, Crohns disease, ulcerative colitis), exclude infection-related diseases (syphilis, active Tuberculosis), exclude the tumor.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method C reactive protein;Erythrocyte sedimentation rate ;Interleukin-10;Interleukin-4;Interleukin-6;Tumor necrosis factor Tumor a necrosis factor a;
- Secondary Outcome Measures
Name Time Method